Dr. Ann Newman is currently a pharmaceutical consultant at Seventh Street Development Group with more than 20 years of large pharma and contract research experience.
For 10 years, Dr. Newman performed characterization studies on a wide range of pharmaceutical systems at Bristol-Meyers Squibb, covering drug substance and product scale-up from late drug discovery to launch and manufacturing. After that, she was at SSCI, Inc. overseeing characterization of API and drug product samples, crystallization and polymorph screens, salt selections, quantitative assays, amorphous projects and problem solving for the pharmaceutical industry.
As Vice President of Research and Development at Aptuit, Dr. Newman instituted a company-wide R&D initiative over six global sites and covering areas such as API, preclinical (toxicology, safety, pharmacokinetics), formulation, solids, analytical, clinical packaging, and regulatory.
Dr. Newman also holds an adjunct faculty position in Industrial and Physical Pharmacy at Purdue University and is a collaborator on 40 publications and over 75 technical presentations.